-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Maintains Buy on Trevi Therapeutics, Raises Price Target to $28

Benzinga·08/14/2026 12:52:38
Listen to the news
Jones Trading analyst Debanjana Chatterjee maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and raises the price target from $24 to $28.